2026 Selumetinib latest price information update

Selumetinib(Selumetinib) is a targeted drug mainly used to treat neurofibromatosis type 1(NF1). With the launch of the original drug selumetinib in China, its application in the treatment of NF1 has attracted more and more attention.

In China, the original drug of selumetinib has been included in the scope of medical insurance, and patients can enjoy certain reimbursement discounts. Common specifications are10mg 60 capsules and 25mg 60 capsules. The price of each box is roughly more than 20,000 yuan. However, as the market continues to change, prices may fluctuate based on different drug suppliers and regions. For the international market, the price of selumetinib is relatively high. Taking the European market as an example, the price of 10mg*60 tablets of the original drug may reach around 50,000 yuan. It is worth noting that drug prices are affected by exchange rate fluctuations, so the selling prices in different countries will also vary.

With the emergence of generic drugs, the market competitiveness of selumetinib has improved. Although generic drugs are generally less expensive, they are essentially the same in ingredients and effects as the brand-name drugs. For example, the price of the generic selumetinib produced by Lucius Pharmaceuticals in Laos,10mg*60 tablets, is usually between 1,000 and 2,000 yuan (the specific price will fluctuate due to the exchange rate). The emergence of generic drugs provides patients with more economical treatment options, especially in regions where drug price is an important factor in treatment.

When choosing to purchase selumetinib, patients should consider many factors such as the effectiveness of the drug, acceptable treatment costs, and medical insurance policies. In China, although the price of original drugs is relatively high, the actual payment pressure of patients has been alleviated through the support of medical insurance. For some patients with tight financial conditions, generic drugs undoubtedly provide a more cost-effective option, especially when medical insurance coverage is less or the drug price cannot be fully reimbursed.

Keyword tags: selumetinib, Selumetinib, NF1, neurofibromatosis type 1, price update, original drug, generic drug, drug price, medical insurance reimbursement, drug selection

References:https://alexion.us/-/media/alexion_global/documents/regulatory/north-america/usa/2025/koselugo_uspi.pdf